Diabetes News

There have been many recent regulatory updates in the areas of blood pressure management, dyslipidemia and diabetes management, speakers reported.

Ozempic and similar drugs for diabetes and weight-related conditions were associated with a 40% lower rate of opioid overdose and 50% lower rate of alcohol intoxication in people with opioid and alcohol use disorders, a new study showed.

An analysis of data from young adults with obesity revealed that exposure to higher levels of three types of per-and polyfluoroalkyl substances was associated with more sleep disturbances and shorter sleep duration.

The 19th annual Cardiometabolic Health Congress will be held at the Boston Park Plaza and will feature the latest science in the areas of cardio-renal, obesity, diabetes and dyslipidemia, atherosclerosis, thrombosis and more.

A novel duodenal mucosal renewal procedure followed by once-weekly semaglutide could allow adults with type 2 diabetes to maintain glycemic control without insulin therapy, according to a speaker.

Among younger women in the Middle East, those with overweight or obesity were more likely to have hypertension, diabetes and pregnancy-related issues than those without it, according to data from the ANCORS-YW study.

Children and adolescents diagnosed with COVID-19 were more likely to develop new-onset type 2 diabetes than those who had other respiratory infections, according to data published in JAMA Network Open.

The FDA declined to approve a glucagon receptor agonist to treat congenital hyperinsulinism among infants and children, according to an industry press release.

The FDA announced that tirzepatide, a GIP/GLP-1 dual agonist approved for the treatment of type 2 diabetes and obesity, has been removed from its drug shortage list.

In adults living with HIV, those with three or more metabolic risk factors had a higher risk for developing new-onset diabetes than those without any risk factors, according to new findings from the REPRIEVE trial.